Effective immuno-targeting of the IDH1 mutation R132H in a murine model of intracranial glioma
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effective immuno-targeting of the IDH1 mutation R132H in a murine model of intracranial glioma
Authors
Keywords
IDH1-R132H, Immunotherapy, Glioma, 2-hydroxyglutarate
Journal
Acta Neuropathologica Communications
Volume 3, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-01-20
DOI
10.1186/s40478-014-0180-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumour-infiltrating CD4+ and CD8+ lymphocytes as predictors of clinical outcome in glioma
- (2014) S Han et al. BRITISH JOURNAL OF CANCER
- Sox2 Is Required to Maintain Cancer Stem Cells in a Mouse Model of High-Grade Oligodendroglioma
- (2014) Rebecca Favaro et al. CANCER RESEARCH
- Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer
- (2014) Supriya K. Saha et al. NATURE
- Immunization with a Peptide Containing MHC Class I and II Epitopes Derived from the Tumor Antigen SIM2 Induces an Effective CD4 and CD8 T-Cell Response
- (2014) Haydn T. Kissick et al. PLoS One
- Hominoid-specific enzyme GLUD2 promotes growth ofIDH1R132Hglioma
- (2014) Ruihuan Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Accumulation of 2-hydroxyglutarate in gliomas correlates with survival: a study by 3.0-tesla magnetic resonance spectroscopy
- (2014) Manabu Natsumeda et al. Acta Neuropathologica Communications
- What do we know about IDH1/2 mutations so far, and how do we use it?
- (2013) Craig Horbinski ACTA NEUROPATHOLOGICA
- IDH mutations in tumorigenesis and their potential role as novel therapeutic targets
- (2013) Daniel Krell et al. Future Oncology
- MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis
- (2013) Atsushi Terunuma et al. JOURNAL OF CLINICAL INVESTIGATION
- Intratumoral IL-12 combined with CTLA-4 blockade elicits T cell–mediated glioma rejection
- (2013) Johannes vom Berg et al. JOURNAL OF EXPERIMENTAL MEDICINE
- New checkpoint inhibitors ride the immunotherapy tsunami
- (2013) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- (R)-2-Hydroxyglutarate Is Sufficient to Promote Leukemogenesis and Its Effects Are Reversible
- (2013) J.-A. Losman et al. SCIENCE
- An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells
- (2013) D. Rohle et al. SCIENCE
- D-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane function
- (2012) M. Sasaki et al. GENES & DEVELOPMENT
- IDH mutation impairs histone demethylation and results in a block to cell differentiation
- (2012) Chao Lu et al. NATURE
- Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation
- (2012) Peppi Koivunen et al. NATURE
- IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
- (2012) Sevin Turcan et al. NATURE
- Detection of 2-hydroxyglutaric acid in vivo by proton magnetic resonance spectroscopy in U87 glioma cells overexpressing isocitrate dehydrogenase-1 mutation
- (2012) J. Lazovic et al. NEURO-ONCOLOGY
- Detection of IDH1 mutation in the plasma of patients with glioma
- (2012) B. Boisselier et al. NEUROLOGY
- Immunotherapy against the radial glia marker GLAST effectively triggers specific antitumor effectors without autoimmunity
- (2012) Gabriele Cantini et al. OncoImmunology
- R132H-mutation of isocitrate dehydrogenase-1 is not sufficient for HIF-1α upregulation in adult glioma
- (2010) Susan C. Williams et al. ACTA NEUROPATHOLOGICA
- WT1 peptide vaccinations induce CD4 and CD8 T cell immune responses in patients with mesothelioma and non-small cell lung cancer
- (2010) Lee M. Krug et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor-reactive CD4+T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
- (2010) Sergio A. Quezada et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Update on molecular findings, management and outcome in low-grade gliomas
- (2010) T. David Bourne et al. Nature Reviews Neurology
- Induction of p53-Specific Immunity by a p53 Synthetic Long Peptide Vaccine in Patients Treated for Metastatic Colorectal Cancer
- (2009) F. M. Speetjens et al. CLINICAL CANCER RESEARCH
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
- (2009) Lenny Dang et al. NATURE
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1
- (2009) S. Zhao et al. SCIENCE
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme
- (2008) D. W. Parsons et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now